ResBiotic

ResBiotic sells microbiome-targeted nutraceuticals anchored by its flagship powdered synbiotic, resB®; a one-month supply is $79 ($2.63/day), placing the brand in the premium tier. Capsule SKUs for lung and gut support sit at $89–$99, while a 3-in-1 probiotic spray for kids retails for $39. All products are sold direct-to-consumer through resbiotic.com and Amazon; no brick-and-mortar retail. The company positions itself as the first line to combine clinically dosed probiotic strains with resveratrol and botanicals specifically chosen for respiratory–gut axis support. Every formulation is NSF-certified, dual-listed as both a dietary supplement and medical food, and supported by two peer-reviewed human studies conducted at major U.S. universities. This science-first stance is reinforced by transparent Certificates of Analysis and a medical advisory board of pulmonologists. Core buyers are 30-55-year-old health-optimizing professionals who track HRV, use wearables, and want drug-free ways to manage exercise-induced breathing issues or post-antibiotic recovery. The brand resonates with values of data-driven wellness, clean labels (vegan, non-GMO, allergen-free), and environmental responsibility via carbon-neutral shipping. ResBiotic competes in the fast-growing “precision probiotic” space against generic gut-only blends and mainstream respiratory supplements. It differentiates by coupling airway-specific strains with polyphenol science, publishing human data, and offering MD-staffed telehealth onboarding—moving the category from broad-spectrum gut support to targeted respiratory outcomes.